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Abstract 
 
For driving aptitude assessment (DAA), the analysis of several alcohol biomarkers is essential 
for the detection of alcohol intake besides psycho-medical exploration. 
In Switzerland, EtG in hair (hEtG) is often the only direct marker for abstinence monitoring in 
DAA. Therefore, the suitability of phosphatidylethanol (PEth) was investigated as additional 
biomarker. 
PEth 16:0/18:1 and 16:0/18:2 were determined by online-SPE-LC-MS/MS in 136 blood 
samples of persons undergoing DAA and compared to hEtG, determined in corresponding 
hair segments. 
With a PEth 16:0/18:1 threshold of 210 ng/mL for excessive alcohol consumption, all (n=30) 
but one tested person also had hEtG values ≥30pg/mg. In 54 cases, results are not in 
contradiction to an abstinence as neither PEth (<20ng/mL) nor hEtG (<7pg/mg) was detected. 
In 8 cases both markers showed moderate consumption. Altogether, PEth and hEtG were in 
accordance in 68% of the samples, although covering different time periods of alcohol 
consumption. 
With receiver operating characteristic analysis, PEth was evaluated to differentiate abstinence, 
moderate and excessive alcohol consumption in accordance with hEtG limits. A PEth 
16:0/18:1 threshold of 150ng/mL resulted in the best sensitivity (70.6%) and specificity 
(98.8%) for excessive consumption. Values between 20-150ng/mL passed for moderate 
consumption, values <20ng/mL passed for abstinence.  
As PEth mostly has a shorter detection window (2-4 weeks) than hEtG (up to 6 months 
depending on hair length), changes in drinking behavior can be detected earlier by PEth than 
by hEtG analysis alone. Therefore, PEth helps to improve the diagnostic information and is a 
valuable additional alcohol marker for DAA. 
 
Keywords 
Phosphatidylethanol (PEth) in blood, Alcohol biomarker, Ethyl glucuronide in hair (hEtG), 
Online-SPE-LC-MS/MS  
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Introduction 
 
In Switzerland, administrative regulations require a driving aptitude assessment (DAA) for 
convicted driving under the influence (DUI) of alcohol offenders having a blood alcohol 
concentration of 1.6 ‰ and higher, as prolonged excessive alcohol misuse is suspected above 
this limit [1, 2]. In consequence of a DUI of alcohol offence, the driver’s license is revoked. 
The driver has to pass a DAA, in which the driver’s alcohol consumption habits are evaluated. 
Generally, the affected persons have to prove abstinence over a time period of 6 months (after 
traffic relevant alcohol misuse) up to 12 months (alcohol dependency) prior to re-granting the 
driver’s license, and after re-granting the driver’s license, minimal 12 months of a controlled 
alcohol abstinence are stipulated [3].  
For DAA direct (ethyl glucuronide EtG, ethyl sulfate EtS, fatty acid ethyl esters FAEE) and 
indirect markers (carbohydrate deficient transferrin CDT, γ-glutamyl transferase GGT, mean 
corpuscular volume MCV, aspartate aminotransferase ASAT, alanine aminotransferase 
ALAT) are used [4]. However, EtG in hair (hEtG) often is the only direct marker for 
abstinence monitoring during DAA in Switzerland.  
Hair samples mainly consist of head hair from the posterior region (0 – 5 cm) of the scalp, 
sometimes also from arms, legs and chest.  
EtG is a non-volatile, water-soluble metabolite of ethanol (figure 1) [5]. It is formed by a non-
oxidative phase II metabolism, catalyzed enzymatically by UDP-glucuronosyl transferases, 
which conjugates ethanol with activated glucuronic acid [6]. This reaction constitutes only a 
very small fraction (<0.1%) of the ingested alcohol dose [7, 8]. Depending on the amount of 
consumed alcohol EtG is detectable in blood, urine, tissues, sweat and hair long time after 
termination of ethanol elimination [5, 9].  
Compared to the smaller detection windows of EtG in body fluids, EtG is detectable for 
several months in hair depending on the hair length. Therefore, hEtG is of advantage for long-
term abstinence monitoring in DAA. To differentiate prolonged excessive from moderate 
alcohol consumption the Society of Hair Testing (SOHT) proposes a threshold of 30 pg/mg 
hEtG. A threshold of 7 pg/mg is “non-contradicting to self-reported abstinence”. This 
expression is used, as occasional alcohol consumption cannot always be excluded, and if 
samples less than 3 cm or greater than 6 cm are analyzed for EtG, the results should be 
interpreted with caution [8, 10-12]. 
A direct marker, which has also a potential in the field of abstinence monitoring, is 
phosphatidylethanol (PEth), as it is formed directly after alcohol intake [13, 14].  
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The term PEth represents a group of phospholipid homologues, which are ethyl-esters of 
phosphatidic acid (figure 1). These homologues have two fatty acid chains bound to the 
glycerol backbone in sn-1 and sn-2 position and phosphoethanol in sn-3 position. The fatty 
acid chains typically contain 14 – 22 carbon atoms with 0 – 6 double bonds [15, 16]. PEth 
homologues are present in cell membranes [17] and are biosynthesized from 
phosphatidylcholine (PC) catalyzed by the enzyme phospholipase D (PLD) [18], as long as 
ethanol is present in the organism. Due to an elimination half-life of about four days [17], 
accumulation of PEth is observed after repeated drinking. Therefore, PEth has been discussed 
as marker for detection of prolonged excessive alcohol consumption in several studies [16, 
19-23].  
Furthermore, drinking studies [14, 24] with a repeated alcohol consumption leading to a blood 
alcohol concentration (BAC) of 1 g/kg on each of five or ten subsequent days showed a 
correlation between degree of alcohol consumption and detected PEth concentrations. The 
potential of PEth in abstinence monitoring was shown in another drinking study: After a 
single drinking event leading to an estimated BAC of 1 g/kg and followed by an abstinence 
period of two weeks, PEth was detectable for three up to twelve days [25].  
In this study we investigate the suitability of PEth in blood as an additional diagnostic marker 
for the assessment of drinking behavior by comparing the PEth concentrations in whole blood 
with EtG in proximal hair segments of up to 5 cm length, which is used in routine analysis for 
DAA in Switzerland and in Germany. 
 
Material and methods 
 
Study design 
Blood and corresponding hair samples were obtained from 136 persons undergoing DAA at 
the Department of Traffic Sciences of the Institute of Forensic Medicine at the University of 
Bern, Switzerland. Samples were collected between December 2014 and December 2015. 
Blood was taken on the same day as hair samples and was analyzed for PEth homologues 
16:0/18:1 and 16:0/18:2 by a validated online-SPE-LC-MS/MS method [25]. Hair was 
analyzed for EtG by a modified LC-MS/MS method according to Kummer et al. [26]. Hair 
samples were stored at room temperature. Blood samples were stored at 4 °C prior to analysis 
and were analyzed one week after sampling at the latest.  
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Chemicals and materials 
PEth 16:0/18:1 and PEth 16:0/18:2 were provided by Avanti Polar Lipids (Alabaster, USA). 
EtG and deuterated EtG were purchased from Lipomed (Arlesheim, Switzerland). 
Ammonium acetate, acetone and dichloromethane were obtained from Merck (Darmstadt, 
Germany).  
2-Propanol was obtained from Fisher Scientific (Loughborough, UK), methanol (MeOH) was 
from Biosolve BV (Valkenswaard, Netherlands) and acetonitrile (MeCN) was supplied by 
Agros Organics (New Jersey, USA). Formic acid (98 %) was provided by Fluka 
(Switzerland). HPLC solvents were of gradient grade; all other solvents were of analytical 
grade. 
H2O dest. was produced in-house with a Milli-Q water system from Millipore (Billerica, 
USA).  
Deuterated standards were synthesized in our laboratory from phosphatidylcholine PC 
16:0/18:1 and phosphatidylcholine PC 16:0/18:2, respectively, and D6-ethanol catalyzed by 
phospholipase D [1]. 
EDTA monovettes (volume 3.4 mL) were obtained from Sarstedt (Nümbrecht, Germany). 
Lithium-heparinized whole blood, which was used as blank blood, was donated by volunteers 
who were abstinent from alcohol for at least 4 weeks. Blank hair samples were donated from 
teetotalers. 
 
Determination of PEth in whole blood 
PEth was analyzed in 200 μL of whole blood by online-SPE-LC-MS/MS with a QTrap 3200 
mass spectrometer (AB Sciex, Toronto, Canada). Analytical separation was performed by a 
Luna RP-C5 column, 50 mm x 2 mm, 5 μm particle size (Phenomenex, Brechbühler, 
Schlieren, Switzerland) by gradient elution using ammonium acetate (10mM)/MeCN (30:70, 
v/v) and 2-propanol. The precise details of the validated method can be found in [25].  
 
Determination of EtG in hair 
EtG was determined in hair with a limit of quantification (LOQ) of 3 pg/mg by a validated 
modified LC-MS/MS method according to [26] with a Ultimate 3000 LC-system (Dionex, 
Thermo Fisher Scientific, Reinach, Switzerland) coupled to a QTrap 5500 mass spectrometer 
(AB Sciex, Toronto, Canada). This method is used for routine analysis in the accredited 
laboratory (ISO 17025) of the Institute of Forensic Medicine Bern for samples from DAA 
according to SGRM guidelines [3].  
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Briefly, approx. 30 mg of hair was washed with 3 different solvents (4 mL each of 1. H20, 2. 
acetone, 3. dichloromethane) by subsequent shaking for 4 min and removal of the solvent 
between washing steps. After 1h of drying, the hair was grinded for 5 min (30 1/s) with a ball-
mill (MM400, Retsch, Haan, Germany). The hair powder was extracted for 2 h by ultra-
sonication with 1 mL D5-EtG containing deionized H2O. Further purification of the extract 
was achieved by SPE with Oasis Max cartridges (3cc/60 mg; Waters, Baden-Dättwil, 
Switzerland). The samples were analyzed in MRM mode with online preconcentration using a 
Hypercarb column, 3.0 x 2.1 mm, 5 μm (Thermo Fisher Scientific, Reinach, Switzerland), and 
after switching a two way valve, back-flow elution to the analytical column Zorbax Eclipse, 
50 mm x 4.6 mm, 1.8 μm (Agilent, MSP Kofel, Zollikofen, Switzerland) and gradient elution. 
The following transitions were used: EtG: m/z 221/75 as quantifier and m/z 221/85 as 
qualifier. For the deuterated internal standard D5-EtG the transitions m/z 226/75 (quantifier) 
and m/z 226/85 (qualifier) were used. 
 
Statistic evaluation 
ROC analysis (receiver operating characteristic) was performed with GraphPad Prism 6 by 
classifying the PEth results into three groups depending on hEtG thresholds, suggested by the 
SOHT (hEtG ≥ 30 pg/mg: excessive alcohol consumption; 7 pg/mg ≤ hEtG < 30 pg/mg: 
moderate alcohol consumption; hEtG < 7 pg/mg: “non-contradicting to self-reported 
abstinence”) [10, 11]. 
 
Results 
 
136 samples from persons undergoing DAA were analyzed. The controlled persons were 
between 19 and 78 years old (mean age: 42 ± 15 years), 88.2 % were male (120 male, 16 
female).  
The PEth and hEtG results were distributed into three groups: Excessive alcohol consumption, 
moderate alcohol consumption and sobriety (abstinence from alcohol) according to the 
thresholds suggested by the SOHT [10, 11] for hEtG. For PEth 16:0/18:1, the proposed 
thresholds (210 ng/mL and 20 ng/mL) were obtained from a Swedish study [27] and from 
results of drinking studies [14, 24, 25], meaning that PEth 16:0/18:1 values below 20 ng/mL 
(LOQ of the method) were rated as consistent with abstinence, and PEth 16:0/18:1 values 
above 210 ng/mL were classified to excessive alcohol consumption. For PEth 16:0/18:2 the 
following thresholds were used: PEth 16:0/18:2 ≥ 100 ng/mL: excessive alcohol consumption; 
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20 ng/mL ≤ PEth 16:0/18:2 < 100 ng/mL: moderate alcohol consumption; PEth 16:0/18:2 < 
20 ng/mL: consistent with abstinence. 
With hEtG analysis, excessive alcohol consumption was detected in 37.5 % of the samples; 
and 44.1 % of the samples were consistent with abstinence. Moderate alcohol consumption 
was detected in 18.4 % of the samples. With PEth 16:0/18:1 elevated alcohol consumption 
was detected only in 22.8 % of the samples, but 58.1 % of the samples were already 
consistent with abstinence. Moderate alcohol consumption was detected in 19.1 % of the 
samples. 
29 of 30 persons with PEth 16:0/18:1 ≥ 210 ng/mL had hEtG ≥ 30 pg/mg. Only one person 
was classified into the group of excessive alcohol consumers by PEth analysis whereas hEtG 
indicated moderate consumption (PEth: 450 ng/mL, hEtG: 29 pg/mg).  
In 54 cases neither PEth nor hEtG was detected. In 8 cases PEth was 20 ≤ PEth < 210 ng/mL, 
and hEtG was between 7 and 30 pg/mg, both markers showing moderate alcohol 
consumption.  
Nine tested persons showed excessive alcohol consumption after analyzing hEtG, but PEth in 
blood was negative. There were no tested persons with negative hEtG values and PEth values 
above the threshold for excessive alcohol consumption of 210 ng/mL.  
There was a little overlapping of different PEth and hEtG results between excessive and 
moderate alcohol consumption and between moderate alcohol consumption and abstinence. 
For example hEtG showed excessive alcohol consumption, but the corresponding PEth result 
showed moderate alcohol consumption (8.8 %), or hEtG showed moderate alcohol 
consumption, but PEth was not detectable (11.8 %). There were also tested persons with 
negative hEtG results, whereas PEth was detectable in blood, demonstrating moderate alcohol 
consumption (4.4 %). Thus, very recent alcohol consumption might have taken place, which 
could not be detected in hair, because of the gap of approximately 14 days that hair needs to 
grow out of the scalp before it can be cut. All results are summarized in detail in table 1. 
As also the PEth homologue 16:0/18:2 was included in the column-switching LC-MS/MS 
method, this homologue was also compared to hEtG. Here a value of PEth 16:0/18:2 ≥ 100 
ng/mL was used as threshold to differentiate excessive from moderate alcohol consumption. 
PEth 16:0/18:2 values below 20 ng/mL (LOQ of the method) were regarded as consistent with 
abstinence. With these thresholds, the distribution of results obtained by PEth 16:0/18:1 were 
close to the results obtained by hEtG. With PEth 16:0/18:2 elevated alcohol consumption was 
detected in 22.8 % (hEtG: 37.5 %), abstinence was detected in 61.0 % (hEtG: 44.1 %) and 
moderate alcohol consumption was detected in 16.2 % (hEtG: 18.4 %) of the samples. 
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For PEth 16:0/18:1 and 16:0/18:2, the used thresholds to differentiate abstinence, moderate 
and excessive alcohol consumption were evaluated by ROC analysis. Using the software 
GraphPad Prism 6, the PEth results were classified into three groups depending on hEtG 
(figure 2). All tested persons with hEtG ≥ 30 pg/mg were assumed to have prolonged 
excessive drinking habits, persons with hEtG between 7 – 30 pg/mg were classified to 
moderate alcohol consumption and persons with hEtG < 7 pg/mg were assumed to be 
abstainers or at least there was no contradiction to abstinence. 
Using the suggested “Swedish threshold” of PEth 16:0/18:1 ≥ 210 ng/mL for the 
differentiation of excessive from moderate alcohol consumption, there is a specificity of 98.8 
% and a sensitivity of 58.8 %. With a specificity of 100 % at a threshold of 470 ng/mL, there 
is only a sensitivity of 45.1 %. For the differentiation of excessive from moderate alcohol 
consumption the PEth 16:0/18:1 threshold of 150 ng/mL resulted in the best sensitivity (70.6 
%) and specificity (98.8 %) (figure 3 A). 
For the differentiation of drinking habits (“non-contradicting self-reported abstinence” from 
“moderate alcohol consumption”) the PEth 16:0/18:1 threshold of 20 ng/mL (LOQ) resulted 
in the best compromise for sensitivity (67.1 %) and specificity (90.0 %). With a specificity of 
100 % at a threshold of 87 ng/mL, there is only a sensitivity of 53.9 %. Using the LOD of our 
method of 10 ng/mL, there is a specificity of 86.7 % and a sensitivity of 71.1 % (figure 3 C). 
PEth 16:0/18:1 values between the suggested thresholds of 20 ng/mL and 150 ng/mL would 
pass for moderate alcohol consumption habits. 
Using the suggested “threshold” of PEth 16:0/18:2 ≥ 100 ng/mL, there is a specificity of 98.8 
% and a sensitivity of 58.8 %. With a specificity of 100 % at a threshold of 332 ng/mL, there 
would only be a sensitivity of 33.3 %. For the differentiation of excessive from moderate 
alcohol consumption the PEth 16:0/18:2 threshold of 96 ng/mL resulted in the best sensitivity 
(62.8 %) and specificity (98.8 %) (figure 3 B). 
For the differentiation of abstinence from moderate alcohol consumption the PEth 16:0/18:2 
threshold of 20 ng/mL (LOQ) resulted in the best compromise for sensitivity (63.2 %) and 
specificity (90.0 %). With a specificity of 100 % at a threshold of 93 ng/mL, there would only 
be a sensitivity of 44.7 %. Using the LOD of our method as threshold, which is 10 ng/mL, 
there is a specificity of 88.3 % and a sensitivity of 67.1 % (figure 3 D). PEth 16:0/18:2 values 
between the suggested thresholds of 20 ng/mL and 96 ng/mL would pass for moderate alcohol 
consumption habits.  
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Discussion 
 
Although PEth and hEtG cover different time periods of alcohol consumption, PEth 16:0/18:1 
(thresholds: 210 ng/mL and 20 ng/mL) and hEtG results are in agreement in 68 % of tested 
persons undergoing DAA. By comparing PEth 16:0/18:2 (thresholds: 100 ng/mL and 20 
ng/mL) to hEtG, 66 % of the samples are in agreement. 
Using the thresholds resulting from ROC analysis, results are in agreement in 72 % of the 
samples for PEth 16:0/18:1 (thresholds: 150 ng/mL and 20 ng/mL) (see table 1: numbers in 
line 2 and 3 in italics), for PEth 16:0/18:2 68 % of the samples are in agreement in 
comparison to hEtG (PEth 16:0/18:2 thresholds: 96 ng/mL and 20 ng/mL).  
Of the tested persons, who were classified into the group with moderate alcohol consumption 
habits (7 pg/mg ≤ hEtG < 30 pg/mg), only one person had a PEth 16:0/18:1 value above the 
threshold of 150 ng/mL (sensitivity: 70.6 %, specificity: 98.8 %) resulting from ROC 
analysis. However, the hEtG result is very close to be classified as excessive alcohol 
consumption (hEtG: 29 pg/mg and PEth: 450 ng/mL). These results show that all PEth values 
above this threshold are representing excessive alcohol consumption habits with a specificity 
of 98.8 %, and that the PEth 16:0/18:1 threshold for differentiation of excessive and moderate 
alcohol consumption can be lowered to 150 ng/mL for persons undergoing DAA. 
There is a relatively high number of persons undergoing DAA, who showed excessive alcohol 
consumption habits (37.5 % detected by hEtG analysis, 22.8 % detected by PEth analysis). 
The reason for these findings could be that alcohol consumption habits were assessed soon 
after withdrawal of the driver’s license, and drinking habits might not have been changed in 
the meantime.  
The reasons for minor discrepancies between PEth and hEtG results are due to the different 
detection windows of the matrices and analytes utilized (blood: PEth, hair: EtG). As PEth has 
a shorter detection window (ca. 2 – 4 weeks) than hEtG (several months depending on the hair 
length) [8], changes in drinking behavior can be detected earlier by PEth than by hEtG 
analysis alone. Furthermore, PEth can be directly detected in blood a few hours after alcohol 
ingestion, whereas EtG first needs to be incorporated into the hair bulbus. As the scalp hair 
growth rate can vary from 0.6 – 1.5 cm/month [28] with an average rate of approximately 1 
cm/month, and an additional time period for hair growth (of 10 – 14 days) has to take place 
until the incorporated EtG is found in the proximal segment of head hair, a segment of 5 - 6 
cm length corresponds to a retrospective time window of approximately 6 months [3].  
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Therefore, PEth shows changes in drinking habits earlier than hEtG. Withdrawal or relapse to 
drinking can be shown directly after drinking or cessation of drinking by PEth analysis. 
Additional PEth analysis during DAA increases the sensitivity for uncovering alcohol 
consumption, although a single blood sampling cannot cover a six months period – which is 
the approximated period covered by EtG analysis with a 5 cm proximal hair segment.  
 
Conclusion 
 
PEth is a valuable additional marker for DAA and helps to improve diagnostic information. 
As PEth has a shorter detection window (ca. 2 – 4 weeks) than hEtG (of a 5 cm proximal hair 
segment: approximately 6 months), changes in drinking behavior can be detected earlier by 
PEth in blood than by hEtG analysis alone. Another advantage of PEth analysis is that unlike 
hair, blood is always available in sufficient amounts.  
Therefore, we strongly recommend including the two most abundant PEth homologues in 
human blood, PEth 16:0/18:1 and PEth 16:0/18:2, in routine analysis for DAA. PEth should 
be analyzed in 2 – 3 blood samples over 6 months, as elevated PEth concentrations would 
demonstrate a lack of abstinence which might cause, prior to re-granting the driver’s license, a 
longer withdrawal or, after re-granting the driver’s license, a new withdrawal for a non-
compliant person.  
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Figure 1. Structural formulas of ethyl glucuronide (EtG) and phosphatidylethanol (PEth);  
R1 and R2: fatty-acyl-rests.  
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Table 1. Classification of alcohol consumption habits using hEtG and PEth 16:0/18:1 from 
136 tested persons undergoing DAA. 
For PEth the following thresholds were used: PEth < 20 ng/mL: abstinence*; PEth ≥ 210 
ng/mL, and after ROC analysis PEth ≥ 150 ng/mL: excessive alcohol consumption.  
Drinking habits 
PEth ≥ 210 ng/mL; 
PEth < 20 ng/mL 
PEth ≥ 150 ng/mL; 
PEth < 20 ng/mL 
hEtG 
 
PEth 
 
in % 
(number of samples) 
in % 
(number of samples) 
Excessive 
 
Excessive 
 
22.1 
(30) 
26.5 
(36) 
Excessive 
 
Moderate 
 
8.8 
(12) 
4.4 
(6) 
Moderate 
 
Excessive 
 
0.7 
(1) 
0.7 
(1) 
Moderate 
 
Moderate 
 
5.9 
(8) 
5.9 
(8) 
Abstinence* 
 
Moderate 
 
4.4 
(6) 
4.4 
(6) 
Moderate 
 
Abstinence* 
 
11.8 
(16) 
11.8 
(16) 
Abstinence* 
 
Abstinence* 
 
39.7 
(54) 
39.7 
(54) 
Excessive 
 
Abstinence* 
 
6.6 
(9) 
6.6 
(9) 
Abstinence* 
 
Excessive 
 
0 
(0) 
0 
(0) 
*Non-contradicting self-reported abstinence according to SOHT [11] 
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Figure 2. Classification of PEth 16:0/18:1 and 16:0/18:2 results in comparison to hEtG  
(Consistent with abstinence: hEtG < 7 pg/mg; moderate: 7 ≤ hEtG < 30 pg/mg; excessive: 
hEtG ≥ 30 pg/mg). Three data points (PEth 16:0/18:1 and PEth 16:0/18.2, respectively) are 
outside the axis limit in the column of excessive hEtG (1. PEth 16:0/18:1: 2155 ng/mL, PEth 
16:0/18:2: 1495 ng/mL; 2. PEth 16:0/18:1: 3545 ng/mL, PEth 16:0/18:2: 1945 ng/mL; 3. PEth 
16:0/18:1: 4870 ng/mL, PEth 16:0/18:2: 2685 ng/mL). 
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Figure 3. ROC analysis for PEth vs. hEtG. A: PEth 16:0/18:1 vs. hEtG to differentiate 
excessive from moderate alcohol consumption (AUROC 0.899, P value < 0.0001). B: PEth 
16:0/18:2 vs. hEtG to differentiate excessive from moderate alcohol consumption (AUROC 
0.876, P value < 0.0001). C: PEth 16:0/18:1 vs. hEtG to differentiate abstinence from 
moderate alcohol consumption (AUROC 0.85, P value < 0.0001). D: PEth 16:0/18:2 vs. hEtG 
to differentiate abstinence from moderate alcohol consumption (AUROC 0.84, P value < 
0.0001).  
  
PEth 16:0/18:1  PEth 16:0/18:2  A B 
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